Skip to Videos All Do Insurers’ Have the Urge to Merge? CNBC - Bill George: Theranos under fire Healthy biotech M&A Funtleyder Healthcare is in a holding pattern Fireside Chat People are going to be sick whether Obamacare is repealed or Funtleyder Calls Trump's Health Order a 'Nothing Burger' Consolidation is not the answer for everyone Leerink Partner We're short biotech and large pharma Pro Top picks in health-care sector Johnson & Johnson stock sinks on reports of asbestos in baby powder for decades Two investors make the case for why now is the time to invest in health care stocks E Squared Capital's Les Funtleyder on risks facing healthcare Les Funtleyder on JNJ Opioid Case Health care has more pricing power because demand is inelastic, says E Squared's Les Funtleyder Don't rule out a summer rally for Biotech, says E Squared's Les Funtleyder I'm not sure we know which health care companies will negotiate prices, says E Squared's Funtleyder Biotech is going to have a hard time until the end of rate cycle, says E Squared's Les Funtleyder Investment in procedural medical devices is safer for valuation, says E Squared's Les Funtleyder Everybody will sell first and ask questions later with PBM stocks: E Squared's Les Funtleyder
